Business Annual sales fall 6% to $43.1M for Aleafia The stalwart pot firm is projecting a return to EBITDA-positivity later this year, as it pivots to adult-use sales Nick LabaFebruary 15, 2022
Business Neptune reports Q3 revenue up 17% to $18.4M, net loss of $21M Taking a recent majority stake in a baby food maker, Neptune joins other pot firms expanding broadly into different CPG categories Nick LabaFebruary 10, 2022
Business Canopy’s recreational pot sales drop 18% in Q3 But sales for the firm's BioSteel sports drinks and Storz & Bickel vaporizers have been rising Nick LabaFebruary 9, 2022
Business Nextleaf ups annual sales to $3.4M but cash reserves run low In December, the firm finished a public offering for proceeds of $3.2 million Nick LabaFebruary 3, 2022
Business Cannara Biotech sales recover slightly to $6.6M in Q1 The firm reported its third-straight quarter of positive adjusted EBITDA Nick LabaJanuary 20, 2022
Business Organigram reports 22% revenue gain for 2nd straight quarter The company will be EBITDA-positive by Q3, CEO says Nick LabaJanuary 11, 2022
Business Tilray ekes out Q2 profit despite 16% drop in pot sales For better or for worse, the firm's focus appears to be moving further away from cannabis sales Nick LabaJanuary 10, 2022
Business Kiaro boosts Q3 sales 23% to $7.5M following acquisitions A recent capital raise has boosted the firm's cash position Nick LabaDecember 17, 2021
Business Hexo’s sales spike 31% with $117M loss after steep impairments in Q1 The company is also making a number of new changes to its top management Nick LabaDecember 14, 2021
Business Cannara Biotech ups annual sales 565% to $17.3M While it's now expanded to new markets, almost all of the firm's 2020 sales were in Quebec Natalia Buendia CalvilloDecember 8, 2021